Psoriasis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Bio

Psoriasis Pipeline constitutes 80+ key companies continuously working towards developing 80+ Psoriasis treatment therapies, analyzes DelveInsight.

Psoriasis Overview:

Psoriasis is a chronic inflammatory skin condition characterized by a range of clinical symptoms. It arises from a combination of genetic, environmental, and immunological factors. This non-contagious dermatological disorder affects approximately 2% of the global population. The extent of skin involvement varies between individuals, with psoriasis classified as mild (10%). The most commonly observed form is chronic plaque psoriasis, or psoriasis vulgaris, in which dendritic cells, T lymphocytes, macrophages, neutrophils, and keratinocytes contribute to the formation of skin lesions. For mild to moderate cases, topical treatments are typically the primary approach.

Request for a detailed insights report on Psoriasis pipeline insights @ https://www.delveinsight.com/report-store/psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

"Psoriasis Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Psoriasis Therapeutics Market.

Key Takeaways from the Psoriasis Pipeline Report

DelveInsight's Psoriasis pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for Psoriasis treatment.
In November 2020, Biohaven Pharmaceutical partnered with Weill Cornell Medicine to launch a clinical trial evaluating a Biohaven CGRP-receptor antagonist for the treatment of plaque psoriasis. CGRP, a neuropeptide, is thought to play a key role in the development of inflammatory skin conditions like psoriasis.
Key Psoriasis companies such as Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, Janssen Pharmaceuticals, Can-Fite Biopharma, Arcutis Biotherapeutics, Amgen, Iltoo Pharma, GlaxoSmithKline, Galectin Therapeutics, Evelo Biosciences, Galderma, BioMimetix JV, Menlo Therapeutics Inc., Aristea Therapeutics, UNION Therapeutics, MetrioPharm, Sienna Biopharmaceuticals, and others are evaluating new drugs for Psoriasis to improve the treatment landscape.
Promising Psoriasis pipeline therapies in various stages of development include Topical roflumilast, GSK2982772, and others.

Psoriasis Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Psoriasis Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Psoriasis treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Psoriasis market.

Download our free sample page report on Psoriasis pipeline insights @ https://www.delveinsight.com/sample-request/psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Psoriasis Emerging Drugs

Topical roflumilast: Arcutis Biotherapeutics
GSK2982772: GlaxoSmithKline

Psoriasis Companies

Over 80 key companies are currently developing therapies for psoriasis. Among those with drug candidates in the most advanced stage, namely registered, is Biocad.

DelveInsight's report covers around 80+ products under different phases of clinical development like

Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates

Psoriasis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Intravenous
Subcutaneous
Oral
Intramuscular

Psoriasis Products have been categorized under various Molecule types such as

Monoclonal antibody
Small molecule
Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Psoriasis Therapies and Key Companies: Psoriasis Clinical Trials and advancements @ https://www.delveinsight.com/report-store/psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Psoriasis Pipeline Therapeutic Assessment
• Psoriasis Assessment by Product Type
• Psoriasis By Stage
• Psoriasis Assessment by Route of Administration
• Psoriasis Assessment by Molecule Type

Download Psoriasis Sample report to know in detail about the Psoriasis treatment market @ Psoriasis Therapeutic Assessment @ https://www.delveinsight.com/sample-request/psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Content

1. Report Introduction
2. Executive Summary
3. Psoriasis Current Treatment Patterns
4. Psoriasis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Psoriasis Late-Stage Products (Phase-III)
7. Psoriasis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Psoriasis Discontinued Products
13. Psoriasis Product Profiles
14. Psoriasis Key Companies
15. Psoriasis Key Products
16. Dormant and Discontinued Products
17. Psoriasis Unmet Needs
18. Psoriasis Future Perspectives
19. Psoriasis Analyst Review
20. Appendix
21. Report Methodology

Request the Sample PDF to Get Detailed Insights About the Psoriasis Pipeline Reports Offerings: https://www.delveinsight.com/sample-request/psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.